文献速递传染病防控与疫情报告免疫规划

澳大利亚男男性行为者猴痘疫苗接种的驱动因素、障碍及启示:一项前瞻性观察性混合方法研究(2022-2024)

Drivers, barriers, and implications of mpox vaccine uptake in Australia among gay, bisexual, and other men who have sex with men: results from a prospective observational mixed-methods study (2022-2024).
PubMed 文献 · Vaccine · 2025-12-01

TraX研究为前瞻性观察性混合方法研究,追踪男男性行为者(GBMSM)猴痘疫苗接种。2024年1224名参与者中,社区招募者82.8%至少接种一剂,全体83.7%完成第二剂。57名未接种者质性分析显示低感知风险、服务可及性差、疫苗知识有限和副作用担忧为障碍。

要点

  • 2024年1224名参与者中,82.8%社区招募者至少接种一剂,83.7%完成第二剂。
  • 第一剂接种与居住地男同性恋居民≥5%、HIV感染、近期性传播感染等因素相关。
  • 第二剂完成与年龄较大和非固定关系性行为相关。

核心结论

  • 本研究观察到第一剂猴痘疫苗高接种率和第二剂高完成率。
  • 多数参与者决策与公共卫生指南一致,但部分人低估自身风险。
  • 作者认为澳大利亚2024年猴痘疫情可能反映人群保护不足。
  • 作者建议通过解决副作用担忧、简化接种流程和提高个人风险因素意识来提高接种率。

研究设计与样本

  • TraX研究为2022年建立的前瞻性观察性混合方法研究,对象为GBMSM及其性伴侣。
  • 通过每周调查追踪猴痘疫苗接种情况。
  • 通过等待名单、疫苗中心和社区网络招募3596名参与者。
  • 2024年1224名参与者纳入本分析。
  • 采用两个多变量逻辑回归模型识别接种一剂和两剂的预测因素。

主要发现

  • 社区招募参与者中82.8%至少接种一剂。
  • 全体参与者中83.7%完成第二剂。
  • 第一剂接种与居住地男同性恋居民≥5%、HIV感染、近期性传播感染、更多COVID-19疫苗接种史、非固定关系性行为、群交、国际旅行和猴痘担忧相关。
  • 第二剂完成与年龄较大和非固定关系性行为相关。
  • 57名未接种参与者的质性分析中,多数人因地理位置或性行为认为自身风险低。

临床怎么用

  • 作者建议通过解决副作用担忧、简化接种流程和提高个人风险因素意识来增加疫苗接种率。
  • 原文未据此给出其他推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Unlike other high-income countries that experienced mpox outbreaks in 2022, Australia had low case numbers before a significant resurgence in 2024, with 99 % of cases occurring in males. Vaccine coverage among gay, bisexual, and other men who have sex with men (GBMSM) was estimated at 50 %. We identified drivers and barriers to vaccine uptake and discuss implications for mpox control in Australia. METHODS: The TraX study, established in 2022, was a mixed-method prospective observational study of GBMSM and their sexual partners tracking mpox vaccine uptake through weekly surveys. Two multivariable logistic regression models identified predictors of receiving one and two doses. We analyzed qualitative responses from unvaccinated participants using the Framework Method. RESULTS: A total of 3596 participants were recruited through a waitlist, vaccine hubs, and community networks. In 2024, 1224 responded and were included in this analysis. Among community-recruited participants, 82.8 % had received at least one dose, associated with living in areas where ≥5 % of residents were gay men, living with HIV, recent sexually transmitted infections (STIs), greater COVID-19 vaccine history, non-relationship sex, group sex, international travel, and mpox concern. Among all participants, 83.7 % had completed the second dose, associated with older age and non-relationship sex. In qualitative analysis of 57 unvaccinated participants, most cited low perceived risk based on geography or sexual behavior. Reported barriers included difficulty accessing services, limited vaccine knowledge, and concerns about side effects. CONCLUSIONS: This study found high uptake of the first mpox vaccine dose and a high rate of second dose completion. Most participants made decisions aligned with public health guidance, though some underestimated their risk. With low vaccine coverage and natural immunity, Australia's 2024 mpox outbreak likely reflected insufficient population-level protection. Australia likely entered 2024 with little infection induced immunity because few cases had occurred in 2022-2023, and with incomplete vaccine coverage among people at ongoing risk. Our findings point to practical steps to prevent future outbreaks by increasing vaccination rates, including addressing side-effect concerns, streamlining vaccination, and improving awareness of personal risk factors.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Hammoud M, Smith AKJ, Sachs O, et al. Drivers, barriers, and implications of mpox vaccine uptake in Australia among gay, bisexual, and other men who have sex with men: results from a prospective observational mixed-methods study (2022-2024). Vaccine. 2025. PMID: 41330186. doi:10.1016/j.vaccine.2025.128041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。